From the RE.WORK series
Elaine Warburton is an entrepreneur with over 25 years’ healthcare and biotechnology experience. With an eclectic background in nursing, genetics, accounting and running hospitals, she currently heads up QuantuMDx Group, one of the most exciting biotechs to emerge onto the ‘precision medicine’ global stage, developing a low cost handheld molecular lab with inbuilt DNA sequencing to help address humanitarian health challenges in both developed and developing nations.
The first assays to be commercialised later in 2015 are in infectious disease and drug resistance testing. Elaine was awarded an OBE in the 2014 Queen’s New Year Honours for services to Innovation in Healthcare.
Just as the internet has revolutionised how we share information, the Internet of Life will transform our healthcare systems globally.
Elaine will be presenting at the upcoming RE.WORK Future Technology Summit in London on 24th & 25th Sept.